Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Important Advances in Oncology
|
January 1, 1991
Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation
G J Bosl, E Strong, L Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene
R T Chlebowski, D E Collyar, M R Somerfield, et al.
Hematology/Oncology Clinics of North America
|
September 24, 1999
Clinical economics of head and neck malignancies
E J Sherman, H S Ruchlin, J S Holden, et al.
Oncology (Williston Park, N.Y.)
|
March 1, 1992
Current status of larynx preservation with multimodality therapy
D G Pfister, L B Harrison, E W Strong, et al.
Cancer Research
|
August 1, 1990
Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy
D G Pfister, C K Wells, C K Chan, et al.
The American Journal of Medicine
|
February 1, 1990
Diagnostic criteria and technology as sources for changing incidences of pulmonary diseases
C K Wells, C K Chan, E B Milstone, et al.
Plastic and Reconstructive Surgery
|
February 9, 1999
Factors associated with complications in microvascular reconstruction of head and neck defects
B Singh, P G Cordeiro, E Santamaria, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer
S L Wolden, P G Steinherz, D H Kraus, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
January 1, 1994
Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer
D G Pfister, D Bajorin, R Motzer, et al.
Investigational New Drugs
|
February 1, 1993
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer
D G Pfister, D Bajorin, R J Motzer, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Important Advances in Oncology
|
January 1, 1991
Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation
G J Bosl, E Strong, L Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene
R T Chlebowski, D E Collyar, M R Somerfield, et al.
Hematology/Oncology Clinics of North America
|
September 24, 1999
Clinical economics of head and neck malignancies
E J Sherman, H S Ruchlin, J S Holden, et al.
Oncology (Williston Park, N.Y.)
|
March 1, 1992
Current status of larynx preservation with multimodality therapy
D G Pfister, L B Harrison, E W Strong, et al.
Cancer Research
|
August 1, 1990
Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy
D G Pfister, C K Wells, C K Chan, et al.
The American Journal of Medicine
|
February 1, 1990
Diagnostic criteria and technology as sources for changing incidences of pulmonary diseases
C K Wells, C K Chan, E B Milstone, et al.
Plastic and Reconstructive Surgery
|
February 9, 1999
Factors associated with complications in microvascular reconstruction of head and neck defects
B Singh, P G Cordeiro, E Santamaria, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2000
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer
S L Wolden, P G Steinherz, D H Kraus, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
January 1, 1994
Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer
D G Pfister, D Bajorin, R Motzer, et al.
Investigational New Drugs
|
February 1, 1993
A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer
D G Pfister, D Bajorin, R J Motzer, et al.
Page
of 6